ProCE Banner Activity

Treatment Selection and Optimization in MCL From a European Union Perspective

Slideset

Downloadable slideset covering the current treatment algorithm, guidelines, and evidence-based approaches for the optimal integration of available treatments into the management of patients with mantle cell lymphoma (MCL) with careful consideration of patients’ age, fitness level, presence of high-risk features, preexisting comorbidities, and concomitant medications.

Released: April 15, 2025

Expiration: October 14, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Faculty Disclosure

Primary Author

Mats Jerkeman, MD, PhD: consultant/advisor/speaker: AbbVie, AstraZeneca, Kite/Gilead, Lilly, Roche.